Novartis AG
Process and intermediates
Last updated:
Abstract:
The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.
Status:
Grant
Type:
Utility
Filling date:
8 Dec 2016
Issue date:
13 Aug 2019